Developer of bioencapsulation based life science and therapeutic products. The company offers drug delivery systems for the formulations of cancer and diabetes treating drugs.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 08-Dec-2014 | 000.00 | Completed | Generating Revenue | ||
7. Grant | 21-Nov-2012 | 00000 | 000.00 | Completed | Generating Revenue | |
6. Later Stage VC (Series C) | 18-May-2011 | 00.000 | 000.00 | Completed | Generating Revenue | |
5. Later Stage VC | 13-Sep-2010 | 00.000 | 000.00 | Completed | Generating Revenue | |
4. Later Stage VC | 07-Dec-2009 | 00.000 | 00.000 | Completed | Generating Revenue | |
3. Early Stage VC | 15-Aug-2007 | 00.000 | 00.000 | Completed | Product Development | |
2. Early Stage VC | 15-Feb-2006 | $574K | $1.49M | Completed | Product Development | |
1. Early Stage VC | 07-Jul-2004 | $914K | $914K | Completed | Product Development |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sue Grieve Ph.D | Development Director | ||
David Webb | Pharmaceutical Operations Director | ||
Timothy Sparey Ph.D | Chief Executive Officer |
Name | Representing | Role | Since |
---|---|---|---|
Simon Turton Ph.D | Self | Chairman | 000 0000 |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Brightlands Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Development Bank of Wales | Venture Capital | Minority | 000 0000 | 000000 0 | |
Disruptive Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
E-Synergy | Venture Capital | Minority | 000 0000 | 000000 0 | |
FusionIP | Venture Capital | Minority | 000 0000 | 000000 0 |